| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 07/23/2003 | CN1431206A Xanthonoid glycoside compound with its benzapyrene [a] substituted by hydroxy-propyl and photochemistries synthesizing method |
| 07/23/2003 | CN1431205A Extraction agent used for extracting proanthocyanidin from plants and extracting method |
| 07/23/2003 | CN1431204A Method for preparing water-soluble soybean aglycon and its applications |
| 07/23/2003 | CN1431203A 7-substitution-1-hero hydrogenated-2-ketone and ramification as well as its synthesizing method and usage |
| 07/22/2003 | US6596873 2-and 2,5-substituted phenylketoenols |
| 07/22/2003 | US6596761 Cosmetic and dermatological preparation with flavonoids |
| 07/22/2003 | US6596758 Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
| 07/22/2003 | US6596743 Carbamic acid derivatives |
| 07/22/2003 | US6596723 Fungal efflux pump inhibitors |
| 07/22/2003 | US6596522 Compositions and optical methods for determining transmembrane potentials across plasma membrane of biological cells |
| 07/22/2003 | US6596481 Dual markers |
| 07/22/2003 | CA2275166C Novel benzopyran derivatives |
| 07/17/2003 | WO2003057254A1 Preventives/remedies for urinary disturbance |
| 07/17/2003 | US20030135045 Glycoprotein IIb/IIIa antagonists |
| 07/17/2003 | US20030134859 Substituted 2-chloro-5-nitrobenzamides; treating retrograde osteoporosis and diabetes mellitus |
| 07/17/2003 | US20030134274 Nucleic acid sequence detection employing probes comprising non-nucleosidic coumarin derivatives as polynucleotide-crosslinking agents |
| 07/17/2003 | US20030133940 Medicaments for chemotherapeutic treatment of disease |
| 07/17/2003 | CA2471760A1 Preventives/remedies for urinary disturbance |
| 07/16/2003 | EP1326598A1 Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts |
| 07/16/2003 | EP1326593A1 ESTROGEN RECEPTOR-$g(b) LIGANDS |
| 07/16/2003 | EP1235823B1 H-annellated benzo [f]chromenes |
| 07/16/2003 | EP1070069B1 Bicyclic hydroxamic acid derivatives |
| 07/16/2003 | EP1069121B1 Reagent for singlet oxygen determination |
| 07/16/2003 | CN1430596A New gamma selective retinoids |
| 07/16/2003 | CN1114600C Process for continuously synthesizing coumarin |
| 07/16/2003 | CN1114351C Aglucone isoflavone enriched vegetable protein whey and process for making the same |
| 07/15/2003 | US6593480 Obesity, hyperglycemia |
| 07/15/2003 | US6593359 Use of a RAR-γ-specific agonist ligand for increasing the rate of apoptosis |
| 07/10/2003 | WO2003055872A1 3h-naphtho[2,1-b]-pyrane derivatives and the use of the same |
| 07/10/2003 | WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS |
| 07/10/2003 | WO2003055847A1 Carboxylic acid derivative |
| 07/10/2003 | WO2003055478A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
| 07/10/2003 | US20030130526 Process of production of high purity tocopherols |
| 07/10/2003 | US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 07/10/2003 | US20030130505 Nonsteroidal agonists and antagonists |
| 07/10/2003 | US20030130342 Such as anticoagulant 3-(6-(4-(aminoiminomethyl)phenyl methoxy)-2-methyl-2H-1-benzopyran-2-yl)propanoic acid hydrochloride |
| 07/10/2003 | US20030130232 Amidine derivatives, the preparation and use thereof as medicaments with LTB4 antagonistic effect |
| 07/10/2003 | US20030129670 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential |
| 07/10/2003 | US20030129263 Recovery of isoflavones from soy molasses |
| 07/10/2003 | CA2482392A1 Carboxylic acid derivative |
| 07/09/2003 | EP1325748A1 Preventive or therapeutic drugs for cancers containing cyanidin compounds as the active ingredient |
| 07/09/2003 | EP1324995A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 07/09/2003 | EP1324994A2 Tricyclic compounds and uses thereof |
| 07/09/2003 | EP1324984A1 Butenolide and pentenolide derivatives as kinase inhibitors |
| 07/09/2003 | EP0901483B1 Benzofurans and benzopyrans as chronobiological agents |
| 07/09/2003 | CN1429210A Substituted thioacetamides |
| 07/09/2003 | CN1429197A Shortened synthesis of 3,3-diarylpropylamine derivatives |
| 07/09/2003 | CN1428341A Chemical semi-synthesis method for preparing high-content natural d-alpha tocopherol |
| 07/09/2003 | CN1428340A 3,7,8-trisubstituted-5-hydrobenzo-gamma-pyranone compound and its preparation method |
| 07/08/2003 | US6589983 Antiarrhythmic agents having the prolongation effect on the functional refractory period as a main function |
| 07/08/2003 | US6589962 Certain alpha -hydroxy- gamma -(((carbocyclic- or heterocyclic- substituted)amino)carbonyl)alkanamide derivatives are described as inhibitors of HIV protease and inhibitors of HIV replication. These compounds are useful in |
| 07/08/2003 | US6589736 Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 07/03/2003 | WO2003053977A1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 07/03/2003 | WO2003053948A1 Isochroman compounds for treatment of cns disorders |
| 07/03/2003 | WO2003053927A1 Piperazine derivative |
| 07/03/2003 | WO2003053915A2 Compounds for the treatment of inflammatory disorders |
| 07/03/2003 | WO2003053407A1 Liposomal delivery of vitamin e based compounds |
| 07/03/2003 | WO2003010116A3 Process for isolating phenolic compounds |
| 07/03/2003 | US20030125573 Using biological system to produce farnesol or geranylgeraniol which is chemically converted into alpha-tocopherol or an alpha-tocopheryl ester |
| 07/03/2003 | US20030125571 7-hydroxy-3-(4-hydroxyphenyl)-3-methyl-chromene or thiochromene-4-yl)-pentafluoroalkanoic acid or a hydrate useful antiestrogenic or anticarcinogenic agent (breast cancer) |
| 07/03/2003 | US20030125376 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 07/03/2003 | US20030125356 Reacting a methylketophenolic compound with a benzaldehyde compound to produce an intermediate, cyclizing the intermediate in presence of a base; anticarcinogenic agent, and treats diseases induced by cell proliferation |
| 07/03/2003 | CA2471107A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators |
| 07/03/2003 | CA2470808A1 Piperazine derivative |
| 07/03/2003 | CA2469278A1 Isochroman compounds for treatment of cns disorders |
| 07/02/2003 | EP1323160A1 Optical data carrier containing a phthalocyanine colouring agent as a light absorbing compound in the information layer |
| 07/02/2003 | EP1322906A1 Optical data storage device containing a co-phthalocyanin complex in the optically writable information layer |
| 07/02/2003 | EP1322632A1 N-disubstituted carbamoyloxy flavones |
| 07/02/2003 | EP1322631A2 Methods of providing and using compounds ( retinoids ) having activity as inhibitors of cytochrome p450rai |
| 07/02/2003 | EP1322598A1 Nitroso diphenylamine derivatives |
| 07/02/2003 | EP0980364B1 Process for preparing coumarin sulphonates |
| 07/02/2003 | CN1427003A Baicalein 8-position substituted methylamine like derivative and its preparation method |
| 07/01/2003 | US6586460 Administering heterocyclic ethers or sulfides to induce apoptosis, cell differentiation and as anticarcinogenic agents |
| 07/01/2003 | US6586454 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 07/01/2003 | US6586201 Method of chromatographic isolation for non-glyceride components |
| 06/26/2003 | WO2003052106A1 Method of screening compounds |
| 06/26/2003 | WO2003051864A1 Isoflavonoid conjugates, compositions thereof and therapeutic methods involving same |
| 06/26/2003 | WO2003051863A1 SUBSTITUTED 6H-DIBENZO[c,h]CHROMENES AS ESTROGENIC AGENTS |
| 06/26/2003 | WO2003051842A2 Compositions decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | WO2003051841A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/26/2003 | WO2003051825A1 Human adam-10 inhibitors |
| 06/26/2003 | WO2003002491A3 ENANTIOSELECTIVE TRANSFORMATION OF α, β-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS |
| 06/26/2003 | US20030120094 For improved binding of CB1/CB2 receptors; side effects reduction |
| 06/26/2003 | US20030120093 Reacting cytotoxic hydrofuranoxanthones with palladium complex and benzoquinone in presence of dimethyl sulfoxide; antiproliferative/antitumor agents; topoisomerase inhibitors; downregulating oncogenes |
| 06/26/2003 | US20030119759 Recovery of isoflavones from soy molasses |
| 06/26/2003 | US20030118675 Recovery of isoflavones from soy molasses |
| 06/26/2003 | CA2473938A1 Human adam-10 inhibitors |
| 06/26/2003 | CA2470311A1 Method of screening compounds |
| 06/26/2003 | CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/25/2003 | EP1320300A1 Food supplement |
| 06/25/2003 | EP1025086B1 Benzamidine derivatives as factor xa inhibitors |
| 06/25/2003 | CN1112110C Process for extracting high purity tea polyphenol, tea pigment and tea caffeine from tea |
| 06/24/2003 | US6583319 Cyclic compounds having a cycloalkylene chain |
| 06/24/2003 | US6583174 Bi-cyclic compound dissolved in a glyceride; 7-((1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo(4,3,0)nonane -8-one-7-yl)heptanoic acid |
| 06/24/2003 | US6583168 Sulfonated diarylrhodamine dyes |
| 06/24/2003 | US6583118 Chondroprotective agents |
| 06/19/2003 | WO2003050106A1 Coumarin compound |
| 06/19/2003 | WO2003050105A2 Catalytic asymmetric synthesis of optically active compounds |
| 06/19/2003 | WO2003049702A2 Vanilloid receptor ligands and their use in treatments |
| 06/19/2003 | WO2003005960A3 Novel bicyclic and tricyclic cannabinoids |